Sister Institution Signing Ceremony
August 28, 2015. The landmark and historic moment of signing ceremony of Sister Institution Network between MD Anderson Cancer Center and Siriraj Hospital and Bangkok Hospital was commemorated by the Senior Vice President of MD Anderson Cancer Center, Dr Oliver Bogler; Prof. Udom Kachintorn, President of Mahidol University; Prof. Prasit Watanapa, Dean of Faculty of Medicine, Siriraj Hospital; Dr. Chatree Duangnet, Executive Vice President and Group Chief Operating Officer – Medical affairs, BDMS; Prof. Surapol Issaragrisil, PCU Director of Hematology Center, Wattanosoth Hospital. This relationship exemplifies a lifelong collaboration for excellence in edcuation and improvement in patient care.
August 28-29, 2015. Another successful year of completion of AUBHO2015 Conference, Bangkok, Thailand. This regional conference afforded opportunity for collaboration and growth. Eminent speakers from Thailand, Europe, China and India discussed sbout novel advancements and future of oncology care. Dr Qian Jian from Pekin University brought the unique perspective of patient inout and feedback on the usage of tyrosine kinase inhibitors. Dr Ashok Vaid from Medanta Hospital, New Delhi spoke about the advancements in the field of immuno-oncology for lung cancer. Dr Suradej discussed the breakthrough improvement in stem cell transplant for Thalassemia patients. Dr Didier Blaise discussed novel approach to elderly patient with hematologic malignancies. In addition, special immunotherapy symposium dedicated to the in-depth discussion of novel cell therapy and immne manipulation were discussed with a group of young physicians. We look forward to next year: AUBHO2016: August 26-27, 2016.
July 2015: APHCON published first collaborative study using data obtained from BTG2015, Beijing China. There will be 6 additional papers that will be published.
July 2015: Winners of MDRing challenge at Chinese Association of Hematology Conference, Shenyang, China
JAN 9, 2015: The University of Texas MD Anderson Cancer Center was presented the People’s Republic of China International Science and Technology Cooperation Award at a ceremony held Jan. 9 at Beijing’s Great Hall of the People.
The event, attended by Chinese President Xi Jinping, Premier Li Keqiang, and Vice Premier Liu Yandong, recognized MD Anderson’s many international ties to sister institutions in China with which it shares collaborative programs in training, education and patient care. The award is granted through the Chinese State Council to foreign scientists, science and technology engineers and managers, or organizations that have “made important contributions to China’s bilateral or multilateral scientific and technological cooperation.”
Oliver Bogler, Ph.D., senior vice president for academic affairs accepted the award on behalf of MD Anderson. Ta-Jen Liu, Ph.D., project director of global academic programs, also attended the ceremony.
“Cancer is a significant challenge worldwide,” said Bogler. “Every country has a unique spectrum of cancers, influenced by factors such as population and environment, and collaborating to study these cancers is critical to making progress. China in particular offers tremendous opportunities for saving lives through joint cancer research with top scientists and the government’s commitment to fighting cancer.”
Bogler added that collaborations with Chinese partners have been productive in areas such as cancer screening, liver and lung cancer treatment, and cooperation in clinical trials and basic research studies.
“It is increasingly important to share information and create ties that help all nations in our collective fight against cancer,” said Ron DePinho, M.D., president of MD Anderson. “Receiving this coveted award from China is an honor for our institution and one that speaks to our commitment to collaboration, here at home and across the globe.”
MD Anderson was nominated for the award by its sister institution, Sun Yat-sen University Cancer Center in Guangzhou. Other MD Anderson sister institutions include the Chinese Academy of Medical Sciences Cancer Institute and Hospital, Beijing; Tianjin Medical University Cancer Institute and Hospital; Fudan University Shanghai Cancer Center; and the Sir YK Pao Centre for Cancer, Chinese University of Hong Kong.
SIRIRAJ and BANGKOK HOSPITAL join